Records containing: Treatment-resistant Depression
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Precision Targeting of Propofol-induced Electroencephalographic Slow Waves: a Novel Phase I Paradigm for Treatment-resistant Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-11-05Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)
-
CLINICAL_TRIALS study record update · 2025-09-05Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression: a Randomized, Double-blind Placebo-control Study
-
CLINICAL_TRIALS study record update · 2025-07-24Combining Hedonic Olfactory and BRAin Stimulations in Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2025-05-31A Randomized, Double-blind, Placebo-controlled, Phase 2b Trial With an Open-label Extension to Determine the Safety and Efficacy of GH001 in Patients With Treatment-resistant Depression
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-30Remotely Delivered Physical Activity Program for Treatment-Resistant Depression: A Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-04-25Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-01-20A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression
-
CLINICAL_TRIALS study record update · 2024-11-14Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG
-
CLINICAL_TRIALS study record update · 2023-10-12Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in Persistently Depressed Treatment-resistant Inpatients: Efficacy, Moderators, and Mediators of Change
-
CLINICAL_TRIALS study record update · 2023-01-13The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression Via Reelin-Apoer2-NMDAR Pathway- Mediated Synaptic Plasticity
-
CLINICAL_TRIALS study record update · 2022-11-03Controlled Randomized Clinical Trial to Assess Efficacy of Deep Brain Stimulation (DBS) of the slMFB in Patients With Treatment Resistant Major Depression
-
CLINICAL_TRIALS study record update · 2022-09-16Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2022-08-17New Form of Brain Stimulation Targeting Dorsomedial Prefrontal Cortex in Treating Refractory Depression and the Predictive Biomarkers of Antidepressant Efficacy
-
CLINICAL_TRIALS study record update · 2022-04-20Alternative Treatments to Help Late-Life Depression Study Protocol
-
CLINICAL_TRIALS study record update · 2021-05-10A Prospective Study on the Psychosocial Characteristics and Non-pharmacological Intervention of Patients With Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2019-12-03Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression
-
CLINICAL_TRIALS study record update · 2019-04-29An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2019-04-19A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2019-04-18A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2018-06-26Phase 2 Optimization of the Antidepressant Action of Ketamine in Treatment-Resistant Depression and Investigations on Its Mechanism of Action